IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

LOBEFARO, RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.306
AS - Asia 1.062
NA - Nord America 963
SA - Sud America 120
AF - Africa 25
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.480
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 915
DE - Germania 710
SG - Singapore 323
CN - Cina 307
IT - Italia 225
HK - Hong Kong 136
BR - Brasile 96
BD - Bangladesh 69
VN - Vietnam 68
RU - Federazione Russa 61
SE - Svezia 60
GB - Regno Unito 57
IN - India 54
NL - Olanda 50
FR - Francia 47
FI - Finlandia 31
CA - Canada 27
IE - Irlanda 22
JP - Giappone 18
ID - Indonesia 15
CI - Costa d'Avorio 14
TR - Turchia 14
UA - Ucraina 9
DK - Danimarca 8
KR - Corea 8
PH - Filippine 8
MX - Messico 7
AR - Argentina 6
PL - Polonia 6
BE - Belgio 5
IQ - Iraq 5
PK - Pakistan 5
SA - Arabia Saudita 5
UZ - Uzbekistan 4
BO - Bolivia 3
CH - Svizzera 3
CO - Colombia 3
EC - Ecuador 3
ES - Italia 3
JM - Giamaica 3
JO - Giordania 3
MA - Marocco 3
NP - Nepal 3
PE - Perù 3
TT - Trinidad e Tobago 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
CL - Cile 2
EG - Egitto 2
IL - Israele 2
IR - Iran 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
RO - Romania 2
TH - Thailandia 2
AP - ???statistics.table.value.countryCode.AP??? 1
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
NG - Nigeria 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TM - Turkmenistan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.480
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 660
Ashburn 171
Singapore 155
Hong Kong 121
San Jose 89
Chandler 80
Dallas 68
Milan 54
Hefei 45
Beijing 41
Council Bluffs 41
New York 37
Ho Chi Minh City 26
Bengaluru 24
Los Angeles 24
Dublin 22
Southend 22
Helsinki 19
Munich 19
Guangzhou 18
Boardman 16
Santa Clara 16
Buffalo 15
Abidjan 14
Hanoi 14
Lauterbourg 14
Moscow 14
Princeton 13
Tokyo 13
São Paulo 12
Wilmington 12
Fairfield 11
Nuremberg 11
Shanghai 10
Cangzhou 9
Istanbul 9
Jakarta 9
Ottawa 9
Cambridge 8
Hyderabad 8
Nanjing 8
Seattle 8
Turin 8
Lafayette 7
London 7
Monza 7
Phoenix 7
Turku 7
Ann Arbor 6
Da Nang 6
Düsseldorf 6
Fuzhou 6
Naples 6
Seoul 6
Atlanta 5
Brussels 5
Dearborn 5
Houston 5
Lappeenranta 5
Pessac 5
Pune 5
Rho 5
Shenyang 5
Toronto 5
Warsaw 5
Woodbridge 5
Augusta 4
Bochum 4
Hillsboro 4
Manchester 4
McAllen 4
Stockholm 4
Voghera 4
Amman 3
Barnet 3
Bologna 3
Brooklyn 3
Changsha 3
Charlotte 3
Columbus 3
Delhi 3
Denver 3
Eitensheim 3
Fortaleza 3
Hangzhou 3
Islamabad 3
Jinan 3
Las Vegas 3
Memphis 3
Milwaukee 3
Montreal 3
Nanchang 3
New Delhi 3
Padua 3
Parma 3
Perugia 3
Pescara 3
Philadelphia 3
Roubaix 3
Salt Lake City 3
Totale 2.237
Salva come PNG Salva come JPEG
Nome #
PillarX: A Microfluidic Device to Profile Circulating Tumor Cell Clusters Based on Geometry, Deformability, and Epithelial State 321
The landscape of actionable gene fusions in colorectal cancer 275
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer 247
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma : Myth or Reality? 233
Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape 226
Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial 220
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin 219
The pan-immune-inflammation-value predicts the survival of patients with human epidermal growth factor receptor 2 (Her2)—positive advanced breast cancer treated with first-line taxane-trastuzumab-pertuzumab 191
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology 190
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer 181
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications 176
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program 167
“Systemic strategy at the patient’s service”: A congress report on supportive care in oncology 164
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors 162
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers 155
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis 119
Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis 105
Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implications 105
Oral Capecitabine-Vinorelbine is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer 104
Totale 3.560
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.454
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/202281 5 2 4 2 2 3 0 7 8 13 1 34
2022/2023264 26 26 22 26 21 51 5 27 24 6 23 7
2023/2024638 21 10 11 8 45 49 101 77 43 79 105 89
2024/2025948 80 86 84 98 47 36 67 62 62 96 74 156
2025/20261.490 175 139 166 109 104 67 199 48 132 110 195 46
Totale 3.560